Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin

被引：0
|
作者：
Carroll B. Leevy
机构：
[1] University of Medicine & Dentistry of New Jersey,Department of Medicine, Division of Gastroenterology/Hepatology
[2] New Jersey Medical School Liver Center,undefined
来源：
Digestive Diseases and Sciences | 2008年 / 53卷 / 7期
关键词：
D O I：
10.1007/s10620-008-0252-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2009 / 2009
相关论文
共 50 条
  • [31] Hashimoto encephalopathy with pegylated interferon alfa-2b and ribavirin
    Deutsch, M
    Koskinas, J
    Tzannos, K
    Vassilopoulos, D
    Mailis, A
    Tolis, G
    Hadziyannis, S
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (10) : 1745 - 1748
  • [32] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers.
    Jacobson, I
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Rovner, D
    Brass, C
    HEPATOLOGY, 2002, 36 (04) : 358A - 358A
  • [33] Neurocognitive changes in patients with chronic hepatitis C receiving interferon alfa-2b and ribavirin
    Kraus, MR
    Schaefer, A
    Scheurlen, M
    GASTROENTEROLOGY, 2004, 126 (04) : A720 - A721
  • [34] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy, and in combination therapy relapsers.
    Jacobson, IM
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Pizov, O
    Brass, C
    HEPATOLOGY, 2001, 34 (04) : 338A - 338A
  • [35] Pegylated interferon alfa and ribavirin for children with chronic hepatitis C
    Rosen, Irit
    Kori, Michal
    Adiv, Orly Eshach
    Yerushalmi, Baruch
    Zion, Nataly
    Shaoul, Ron
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (07) : 1098 - 1103
  • [36] Combination therapy with interferon alfa-2b, ribavirin, and amantadine in chronic hepatitis C non-responders to interferon and ribavirin
    Pande, H
    Thuluvath, PJ
    Jaffer, SA
    Maygers, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S96 - S96
  • [37] Treatment with pegylated interferon alfa-2b in combination with ribavirin improved health-related quality of life compared with interferon alfa-2b plus ribavirin in chronic hepatitis C.
    Gish, R
    Rzowej, N
    Brooks, L
    Brass, C
    Weng, W
    HEPATOLOGY, 2002, 36 (04) : 582A - 582A
  • [38] Efficacy of ribavirin monotherapy following combination therapy with interferon alfa-2b and ribavirin for patients with chronic hepatitis C
    Nagayama, A
    Tanaka, A
    Ankoh, H
    Narita, T
    Izumi, M
    Miyake, K
    Takikawa, H
    HEPATOLOGY RESEARCH, 2005, 32 (02) : 101 - 106
  • [39] Estimating the cost-effectiveness of ribavirin and pegylated interferon alfa-2B for chronic hepatitis C.
    Wong, JB
    HEPATOLOGY, 2000, 32 (04) : 425A - 425A
  • [40] PEGYLATED INTERFERON ALFA-2A VS PEGYLATED INTERFERON ALFA-2B, PLUS RIBAVIRIN, FOR CHRONIC HEPATITIS C GENOTYPE 4 PATIENTS: A RANDOMIZED CONTROLLED TRIAL
    Kamal, Sanaa
    Ghoraba, Dalia
    Nabegh, Leila
    Nasser, Imad
    Motaoe, Mona
    Sayed, Mohamed E.
    Gohary, Iman
    HEPATOLOGY, 2009, 50 (04) : 1025A - 1026A
12345